At present, the first-line medications for hyperuricemia/gout are XOD inhibitors, such as allopurinol (a purine analog and competitive xanthine oxidase inhibitor), or the more renoprotective febuxostat/topiroxostat (a nonpurine analog), which inhibits uric acid production (Figure 1). Here, XDH is linked to hyperuricemia.